This story originally appeared in Biocommerce Week, a newsletter that has been discontinued.
Over the past week, two competing consumer genomics services offered by Decode Genetics and by privately held startup 23andMe were officially launched amid much hype and media attention, but questions remain about how the firms will make money off these services, if insurance companies will cover the services, and whether the US Food and Drug Administration will regulate them.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.